Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 174 results for "glenmark"

Buy Glenmark Pharmaceuticals; target of Rs 840: Axis Direct
Money Control

Top technical calls for today's trade: Buy Escorts, Glenmark P...

Few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher Business Standard, 3 days ago

62 images for glenmark

Money Control, 1 week ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 1 month ago
E Pao!, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control

Glenmark Pharmaceuticals to pay dividend

On or after 03 October 2017
 Business Standard2 weeks ago Glenmark licenses oncology products from US-based APC Therapeutics  Business Standard1 month ago Glenmark, APC Therapeutics ink licensing pact for cancer drug  DNA1 month ago Glenmark Pharmaceuticals enters into licensing agreement with APC Therapeutics  Money Control1 month ago
Money Control

Ruchit Jain on how to trade in Arvind, Glenmark Pharma and DLF

 Myiris1 week ago USFDA gives final nod to Glenmark Pharma for anti-herpes drug  Money Control2 weeks ago Glenmark Pharma receives USFDA nod for Acyclovir ointment USP  Myiris2 weeks ago Glenmark Pharmaceuticals receives ANDA approval for Acyclovir Ointment  Business Standard2 weeks ago

Glenmark Pharma releases investigational skin findings

Drug major Glenmark Pharmaceuticals today came out with positive findings from phase 2a study of GBR 830, an investigational monoclonal anti-body in atopic dermatitis (AD), a chronic skin disease.
 DNA2 weeks ago Cash from out-licensing GBR 830 will be used for repayment of debt: Glenmark  Money Control2 weeks ago Glenmark Pharmaceuticals provides update on Phase 2a study of GBR 830  Business Standard2 weeks ago Glenmark reports positive data in Phase 2a study of 'GBR 830'  Myiris2 weeks ago
Money Control

Nifty Pharma index extends fall; Lupin hits 52-week low

Sun Pharma, Dr Reddy's Lab, Glenmark Pharma and Lupin were down 3% on NSE
 Business Standard2 weeks ago Stocks in the news: ITC, HCL Tech, ICICI Bank, Maruti, Orient Cement, Capital First  Money Control3 weeks ago Stock market prediction for July 3-7: Satish Gupta  Money Control1 month ago Stocks in the news: Dr Reddy#39;s, Glenmark, Reliance Defence, Ramky Infra, Petronet LNG  Money Control1 month ago
Money Control

Glenmark, Cyndea Pharma to develop complex drugs for US, Canada markets

Glenmark has tied up with Spanish firm Cyndea Pharma to develop complex drugs for US and Canada markets. Following the tie up Glenmark will develop soft-gelatin capsule products under technology license from the Spanish drug maker. The partnership allows ...
 Business Standard1 month ago Glenmark partners Cyndea to develop soft-gelatin capsule  DNA1 month ago
Money Control

Buy Adani Ports, Glenmark, Godrej Consumer; sell Dish TV: Sudarshan Sukhani

Sudarshan Sukhani of is of the view that one can buy Adani Ports, Glenmark Pharma and Godrej Consumer Products and can sell Dish TV.
 Money Control1 month ago Buy ACC, Hindustan Unilever; sell Glenmark, Zee Entertainment: Sudarshan Sukhani  Money Control1 month ago Buy AB Nuvo, Godrej Consumer; sell Zee Ent, Bata, Glenmark: Mitessh Thakkar  Money Control1 month ago

Buy Can Fin Homes, Glenmark Pharma, Motherson Sumi Systems: Ashwani Gujral

Ashwani Gujral of suggests buying Can Fin Homes, Glenmark Pharma and Motherson Sumi Systems.
 Money Control3 weeks ago Sell Glenmark Pharma, Tata Motors DVR; buy Godrej Properties: Ashwani Gujral  Money Control2 months ago

Here are Surajit Pal#39;s views on Glenmark Pharma Biocon

In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher shared his views and readings on two stocks from pharma space - Glenmark Pharma and Biocon.
 Money Control2 weeks ago
Money Control

Glenmark gets UK#39;s MHRA nod for OTC sale of anti-malarial drug

"Glenmark Pharmaceuticals Europe has been granted final approval by the MHRA (Medicines and Healthcare products Regulatory Agency) for Maloff Protect, anti-malarial medication, as a pharmacy license in the United Kingdom," Glenmark said in a BSE filing.
 Money Control1 month ago Glenmark gets UK's MHRA nod for OTC sale of anti-malarial drug  DNA1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less